Coronavirus in Hungary – First patients receive domestically produced Remdesivir
The first few Hungarian patients have received doses of the domestically manufactured Covid-19 drug Remdesivir at the clinic of Debrecen University, the university’s press office said on Tuesday.
The drug was given to Covid patients with chronic underlying illnesses first on Monday, the press office told MTI in a statement.
The domestic manufacture of Remdesivir is under way by pharmaceutical company Richter.
Richter has already produced enough clinical trial doses in the initial phase to treat some 250 patients, the innovation and technology ministry said last Friday.
By the end of the month, the drug will be available in enough doses to treat more than 800 patients, a state secretary at the ministry said in a statement. The government contributed 400 million forints (EUR 1.1m) to Richter’s production of the drug, József Bódis said.
Mass manufacture in Hungary of the antiviral drug favipiravir is also under way, Bódis said.
More news about CORONAVVIRUS IN HUNGARY
Read alsoHungary records its highest daily death toll from COVID-19
Source: MTI
please make a donation here
Hot news
Top Hungary news: Fools of ’56? Commemorations, OTP Bank shocks, Hungary free Italian textbook, Diplomatic Charity Fair, Gidran-Leopard, if Trump wins… – 4 November, 2024
Commemorations of the heroes of the 1956 revolution – photos
EU Presidency – Minister Bóka: No EU mechanism to monitor rule of law compliance
Surprising new trends that will revive the Hungarian housing market in 2025
Diplomatic Charity Fair Budapest 2024: a global celebration of culture and charity
Hungarian Parliament again extends the state of emergency
2 Comments
Today, the 16th October, the WHO have released a statement saying that ‘Remdesivir makes no substantive to the recovery of patients’.
Reuters reports that the EU wants to renegotiate its order for the drug, now that it has been proven to be of no use in clinical trials.